Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.47 USD | +1.50% | +10.71% | -56.77% |
Apr. 10 | Sector Update: Tech Stocks Decline Premarket Wednesday | MT |
Apr. 10 | Aehr Swings to Fiscal Q3 Non-GAAP Loss, Revenue Drops; Shares Decline Premarket | MT |
Valuation
Fiscal Period: May | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 39.48 | 37.97 | 53.09 | 225.6 | 935.7 | 331.7 | - |
Enterprise Value (EV) 1 | 39.48 | 37.97 | 53.09 | 225.6 | 935.7 | 331.7 | 331.7 |
P/E ratio | - | - | - | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.88 x | 1.7 x | 3.2 x | 4.44 x | 14.4 x | 5.1 x | 4.89 x |
EV / Revenue | 1.88 x | 1.7 x | 3.2 x | 4.44 x | 14.4 x | 5.1 x | 4.89 x |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 22,562 | 23,015 | 23,598 | 26,923 | 28,338 | 28,915 | - |
Reference price 2 | 1.750 | 1.650 | 2.250 | 8.380 | 33.02 | 11.47 | 11.47 |
Announcement Date | 7/18/19 | 7/16/20 | 7/15/21 | 7/19/22 | 7/13/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: May | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 21.06 | 22.29 | 16.6 | 50.83 | 64.96 | 65.06 | 67.86 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | -3.48 | -2.545 | -4.182 | 8.81 | 13.38 | 9.46 | 12.16 |
Operating Margin | -16.53% | -11.42% | -25.19% | 17.33% | 20.59% | 14.54% | 17.92% |
Earnings before Tax (EBT) 1 | -5.208 | - | - | 9.541 | - | 11.77 | 12.21 |
Net income 1 | -5.235 | -2.802 | - | 9.45 | - | 11.7 | 12.09 |
Net margin | -24.86% | -12.57% | - | 18.59% | - | 17.99% | 17.82% |
EPS | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 7/18/19 | 7/16/20 | 7/15/21 | 7/19/22 | 7/13/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: May | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 9.611 | 15.28 | 20.29 | 10.67 | 14.82 | 17.21 | 22.27 | 20.62 | 21.43 | 7.563 | 15.44 | 14.4 | 14.4 | 18 | 23.8 |
EBITDA | - | - | - | - | 3.587 | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | 0.717 | 2.256 | 5.804 | 0.458 | 3.485 | 3.793 | 5.639 | 4.115 | 5.468 | -2.046 | 1.923 | - | - | - | - |
Operating Margin | 7.46% | 14.76% | 28.61% | 4.29% | 23.52% | 22.04% | 25.32% | 19.95% | 25.51% | -27.05% | 12.45% | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | 5.804 | - | 3.743 | - | - | 4.69 | 6.109 | -1.464 | 2.438 | - | - | - | - |
Net income 1 | - | - | 5.794 | - | 3.725 | - | - | 4.674 | 6.089 | - | 2.413 | - | - | - | - |
Net margin | - | - | 28.56% | - | 25.14% | - | - | 22.66% | 28.41% | - | 15.62% | - | - | - | - |
EPS | - | - | - | - | 0.1300 | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 1/6/22 | 3/31/22 | 7/19/22 | 10/6/22 | 1/5/23 | 3/30/23 | 7/13/23 | 10/5/23 | 1/9/24 | 4/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: May | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 7/18/19 | 7/16/20 | 7/15/21 | 7/19/22 | 7/13/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.77% | 332M | |
+25.98% | 360B | |
+18.14% | 121B | |
+10.67% | 19.99B | |
+5.56% | 18.83B | |
+35.96% | 9.77B | |
+24.11% | 9.34B | |
-7.97% | 7.54B | |
-23.57% | 6.08B | |
+36.78% | 5.4B |
- Stock Market
- Equities
- AEHR Stock
- Financials Aehr Test Systems